test

Michael Elgort

@Parkman Healthcare Partners Llc

Latest period2024 - Q3ReportedManaged Assets$783.443MTotal holdings93
Assets growth rate4.94%Assets growth rate (2-Q avg)-1.72%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Parkman Healthcare Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Parkman Healthcare Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 783.443M in assets, with a quarterly growth rate of 4.94% and a 2-quarter average growth rate of -1.72%. The portfolio is managed by Michael Elgort, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
LLYEli Lilly & Co
Recent Activity
Increased 27.58%
4.57%
$35.778M
40,384 shares@ $885.95 avg price
KROSKeros Therapeutics Inc
Recent Activity
Increased 112.35%
3.13%
$24.493M
421,782 shares@ $58.08 avg price
MNKDMannkind Corp
Recent Activity
Increased 37.13%
2.66%
$20.783M
3.304M shares@ $6.3 avg price
KNSAKiniksa Pharmaceuticals Intl
Recent Activity
Increased 16.71%
2.41%
$18.874M
755,244 shares@ $25.0 avg price
VRNAVerona Pharma Plc
Recent Activity
Increased 5.22%
2.31%
$18.023M
626,452 shares@ $28.77 avg price
ITCIIntra-cellular Therapies Inc
Recent Activity
Increased 30.57%
2.26%
$17.676M
241,575 shares@ $73.18 avg price
EWTXEdgewise Therapeutics Inc
Recent Activity
Increased 14.37%
2.24%
$17.537M
657,070 shares@ $26.69 avg price
RCUSArcus Biosciences Inc
Recent Activity
Increased 146.86%
2.01%
$15.684M
1.026M shares@ $15.3 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Increased 11.98%
1.94%
$15.194M
1.086M shares@ $13.99 avg price
NBIXNeurocrine Biosciences Inc
Recent Activity
Increased 12.74%
1.91%
$14.96M
129,840 shares@ $115.23 avg price